Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 15
Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Muneer Yaqub, Aashika Jain, Chinedu Eucharia Joseph, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 1, pp. 7-7
Open Access | Times Cited: 2
The gut microbiota–brain axis in neurological disorders
Mingming You, Nan Chen, Yuanyuan Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 15
Gender Differences in the Interplay between Vitamin D and Microbiota in Allergic and Autoimmune Diseases
Giuseppe Murdaca, Luca Tagliafico, Elena Page, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1023-1023
Open Access | Times Cited: 14
Cell Membrane‐Coated Nanoparticles: A New Frontier in Immunomodulation
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 10
Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes
Hirak Mazumdar, Kamil Reza Khondakar, Suparna Das, et al.
Expert Opinion on Drug Delivery (2024)
Closed Access | Times Cited: 9
Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review
Nicoleta Mihaela Mindrescu, Cristian Guja, Viorel Jinga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3540-3540
Open Access | Times Cited: 8
Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
A. Mincic, Miklós Antal, Lorena Filip, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1832-1849
Closed Access | Times Cited: 8
Microbiome and pancreatic cancer: time to think about chemotherapy
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives
Simone Lista, Antonio Munafò, Filippo Caraci, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102659-102659
Closed Access | Times Cited: 1
Precision Psychobiotics for Gut–Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy
Rebecca F. Slykerman, Naomi Davies, Klára Vlčková, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
The frontier of health: Exploring therapeutic potentials of the microbiome
Mohammad Abavisani, Sobhan Karbas Foroushan, Prashant Kesharwani, et al.
PharmaNutrition (2025), pp. 100435-100435
Closed Access | Times Cited: 1
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review
Zahra Zahedifard, Shirin Mahmoodi, Abdolmajid Ghasemian
Biotechnology and Applied Biochemistry (2025)
Closed Access | Times Cited: 1
Prospects for Leveraging the Microbiota as Medicine for Hypertension
David J. Durgan, Jasenka Zubcevic, Matam Vijay‐Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 7
Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling
Tamer A. Addissouky
Advances in Clinical Toxicology (2024) Vol. 9, Iss. 1, pp. 1-14
Open Access | Times Cited: 6
Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches
Ke Wu, Soon Hwan Kwon, Xuhan Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13121-13121
Open Access | Times Cited: 6
New Brusatol Derivatives as Anti-Settlement Agents Against Barnacles, Targeting HSP90: Design, Synthesis, Biological Evaluation, and Molecular Docking Investigations
Jiang Wang, Tongtong Luan, Pei Cao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 593-593
Open Access
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Towards Personalised Nutrition in Major Orthopaedic Surgery: Elements of Care Process
Matteo Briguglio, Thomas W. Wainwright
Nutrients (2025) Vol. 17, Iss. 4, pp. 700-700
Open Access
System Overview from Physiological and Pathological Standpoints
Gustavo Rodrigues Pedrino, Luíza Toubas Chaul, Virgínia Farias Alves, et al.
(2025), pp. 1-34
Closed Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases
Mohammad Abavisani, Pourya Tafti, Niloofar Khoshroo, et al.
Pathology - Research and Practice (2025), pp. 155931-155931
Closed Access
Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse
Alejandro Borrego-Ruiz, Juan J. Borrego
Genes (2025) Vol. 16, Iss. 4, pp. 403-403
Open Access
Activity of GPCR-targeted drugs influenced by human gut microbiota metabolism
Qihao Wu, Deguang Song, Yanyu Zhao, et al.
Nature Chemistry (2025)
Closed Access
Page 1 - Next Page

Scroll to top